1. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Issue 10323 (29th January 2022) Authors: Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah;... Journal: Lancet Issue: Volume 399:Issue 10323(2022) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lymphoma masquerading as advanced prostate cancer with lymphadenopathy. (May 2017) Authors: Kerr, Lynne; Leung, Hing Y.; Melquiot, Nadja; Arestis, Nik; Sidek, Norma Journal: Journal of clinical urology Issue: Volume 10:Number 3(2017) Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Real‐world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer. (15th October 2017) Authors: Rulach, Robert J.; McKay, Stephen; Neilson, Sam; White, Lillian; Wallace, Jan; Carruthers, Ross; Lamb, Carolynn; Cascales, Almudena; Marashi, Husam; Glen, Hilary; Venugopal, Balaji; Sadoyze, Azmat; Sidek, Norma; Russell, J. Martin; Alhasso, Abdulla; Dodds, David; Laskey, Jennifer; Jones, Robert J... Journal: BJU international Issue: Volume 121:Number 2(2018) Page Start: 268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗